Delivery Order SPE2DB22D3009-SPE2DB24FAJ08
Award Date 11/9/23
Potential Completion Date 11/13/23
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $5,158 by the Defense Logistics Agency (DLA) Troop Support Medical supply chain program. As the prime contractor, Amerisourcebergen will deliver 30 tablets of REXULTI 1 mg to the DLA distribution center located in Conshohocken, Pennsylvania by the period of performance end date of December 19, 2023. No set-aside designation was applied to this order, which was issued against an existing DLA medical supply...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Rexulti 1 mg tablets in a quantity of 30 units, with a ceiling value of $3,390.53. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-competitive set-aside award. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- Amerisourcebergen Drug Corp has received a $5,165.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562620347 REXULTI 1 MG TABLET 30S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to DLA by October 30, 2023 from its headquarters in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, routinely supports DLA Troop Support Medical...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $19,752.82 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 30 boxes of 0.5 mg REXULTI tablets. Performance will take place in Conshohocken, Pennsylvania over one day in late June 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Unites States armed forces by procuring pharmaceuticals and other medical...
- Amerisourcebergen Drug Corp has received a $4,450.29 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562640635 REXULTI 3 MG TABLET 30S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to DLA by October 31, 2023. The delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen's Corporate Office division with no set-aside designation used. Performance will occur...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,494.83 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package), with a completion date of September 22, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,130.00 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of October 22, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,123.59 by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of Rexulti 0.25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 29, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $23,519.35 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 30-count bottles of 1 mg REXULTI tablets. Performance will take place in Conshohocken, Pennsylvania under a single day period from September 7-8, 2023. The contract was awarded utilizing DLA's indefinite-delivery/indefinite-quantity Prime Vendor program, through which the agency obtains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,407.85 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a non-competitive award issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that enables comprehensive...